Experts ID new treatment for type 1 diabetes

12/20/2011 | Sydney Morning Herald (Australia), The

The depletion of heparan sulphate, a type of complex sugar, triggers the destruction of insulin-producing beta cells, a study in The Journal of Clinical Investigation showed. Researchers also found that autoimmune cells produce the enzyme heparanase, which degrades heparan sulphate in beta cells. "This has revealed a new understanding of the development of type 1 diabetes and has identified a new therapeutic strategy for preventing progression of the autoimmune disease and associated complications," researcher Dr. Charmaine Simeonovic said.

View Full Article in:

Sydney Morning Herald (Australia), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Compliance and Ethics Director
Sysmex America, Inc.
Lincolnshire, IL
Director, Site Quality Management
CareFusion
Palm Springs, CA
Compliance Officer-Medical Products
W. L. Gore
Flagstaff, AZ
Project Manager RA - 15000003MD
Abbott
Santa Clara, CA
Director, Site Quality Management
CareFusion
Minneapolis, MN